Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow STAAR SURGICAL CO

Get SEC filing alerts via email and in your feed for STAAR SURGICAL CO

STAA

STAAR SURGICAL CO

About STAAR SURGICAL CO

STAAR Surgical designs, manufactures, and sells implantable lenses for eye refractive surgery, primarily focusing on phakic intraocular lenses (ICLs) made from proprietary Collamer material. Its products treat myopia, hyperopia, astigmatism, and presbyopia, serving ophthalmic surgeons worldwide. The company emphasizes minimally invasive, reversible procedures, with a competitive edge in safety, clinical efficacy, and innovation, operating globally with a strong regulatory and intellectual property foundation.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from STAAR SURGICAL CO

1
1
STAAR SURGICAL CO STAAR Surgical Reports 119.6% Revenue Growth to $93.5 Million in Latest Quarter

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
STAAR SURGICAL CO STAAR Surgical Reports 23.7% Revenue Decline and $80.4 Million Net Loss for Fiscal Year 2026

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
STAAR SURGICAL CO STAAR Surgical Reports Q3 2025 Financial Results with Net Income Decline and Merger Plans

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
STAAR SURGICAL CO STAAR Surgical Reports 55% Decline in Net Sales Amid Restructuring Efforts

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
STAAR SURGICAL CO STAAR Surgical Reports 45% Revenue Decline and $54.2 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
STAAR SURGICAL CO STAAR Surgical Reports 3% Decrease in Net Sales and $20.2 Million Net Loss for Fiscal Year Ending December 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
STAAR SURGICAL CO STAAR Surgical Reports 10% Revenue Growth, Net Income Surge in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments